Overview
Cryptococcal endophthalmitis is a severe fungal infection of the eye, typically occurring in immunocompromised individuals, particularly those with HIV/AIDS. It often presents as a sight-threatening condition requiring prompt diagnosis and treatment [Not directly addressed in provided abstracts].Diagnosis
Clinical suspicion based on immunocompromised status and ocular symptoms (e.g., uveitis, hypopyon) [Not directly addressed in provided abstracts].
Microbiological confirmation via aqueous humor culture or polymerase chain reaction (PCR) for Cryptococcus species [Not directly addressed in provided abstracts].
Histopathological examination showing fungal elements in ocular tissues [Not directly addressed in provided abstracts].Management
First-line treatment: Combination antifungal therapy with amphotericin B or echinocandins (e.g., caspofungin) initially, followed by fluconazole [Not directly addressed in provided abstracts].
Adjunctive treatments: Corticosteroids may be used cautiously to manage inflammation, under close monitoring to avoid immunosuppression [Not directly addressed in provided abstracts].
Monitoring: Regular follow-up with slit-lamp examination, intraocular pressure measurement, and repeat cultures to assess response and prevent relapse [Not directly addressed in provided abstracts].Special Populations
Pediatrics: Limited data; management principles similar to adults but with closer monitoring due to developmental considerations [Not directly addressed in provided abstracts].
Elderly: Increased risk of complications; careful management of comorbidities and immunosuppression [Not directly addressed in provided abstracts].
Comorbidities: Focus on optimizing underlying conditions (e.g., HIV management) to enhance treatment outcomes [Not directly addressed in provided abstracts].Key Recommendations
Initiate prompt antifungal therapy upon clinical suspicion in immunocompromised patients (Evidence: Expert opinion) [Not directly addressed in provided abstracts].
Use combination therapy initially to ensure efficacy against Cryptococcus species (Evidence: Expert opinion) [Not directly addressed in provided abstracts].
Monitor closely for complications including secondary bacterial infections and vision loss (Evidence: Expert opinion) [Not directly addressed in provided abstracts].References
1 Egier D, Orton R, Allen L, Siu VM. Bilateral complete isolated cryptophthalmos: a case report. Ophthalmic genetics 2005. link
2 Saal HM, Traboulsi EI, Gavaris P, Samango-Sprouse CA, Parks M. Dominant syndrome with isolated cryptophthalmos and ocular anomalies. American journal of medical genetics 1992. link